Introduction
============

Community-associated *Staphylococcus aureus* methicillin-resistant (CA-MRSA) infections first emerged in the United States over a decade ago and have since become epidemic ([@evs094-B1]; [@evs094-B23]; [@evs094-B39]). Most of these infections affect skin and soft tissues, but 5--10% are invasive with potentially fatal outcomes ([@evs094-B29]). This CA-MRSA epidemic has been driven by a limited number of clones worldwide [@evs094-B10]), such as pulsed-field gel electrophoresis (PFGE)-type USA300 in the United States. Since the first isolation of USA300 in California in 2000, the pathogen rapidly spread across the United States and by 2004 accounted for the majority of skin and soft tissue infections presenting to Emergency Departments in urban centers ([@evs094-B37]). USA300 remains the leading cause of community-associated bacterial infections in the United States ([@evs094-B44]).

The sequential acquisition of mobile genetic elements (MGEs), such as Panton--Valentine leukocidin (PVL) and arginine-catabolic mobile element (ACME), has been considered as an essential step in the evolution of USA300 ([@evs094-B11]). A previous genome-wide comparison of 10 clinically and geographically diverse USA300 clinical isolates suggested that the majority of these isolates were closely related and had undergone recent clonal expansion and diversification ([@evs094-B30]). This study also demonstrated that a discrete number of single-nucleotide polymorphisms (SNPs) in the core genome of USA300 may equally alter the virulence of a given isolate in a murine sepsis model ([@evs094-B30]). Although some MGEs in USA300 carry classic determinants of virulence, such as toxins or immune evasion molecules ([@evs094-B12]), the molecular factors underlying the fitness and adaptability of these strains remain incompletely determined.

Many studies of the evolution of the *S. aureus* genome relate to anti-infective chemotherapy, where most of the accumulated mutations were likely the result of strong selective pressure of the therapeutic agents. These studies specifically documented the evolution of resistance to vancomycin ([@evs094-B38]; [@evs094-B25], [@evs094-B26]) or linezolid during chemotherapy ([@evs094-B15]). Moreover, whole-genome sequencing of a global collection of sequence type 239 (ST239) *S. aureus* isolates indicated that over a quarter of the detected homoplasies were directly related to evolution of resistance to antibiotics ([@evs094-B20]). This study also estimated that the core genome divergence was approximately 1 SNP per ∼6 weeks. Sequence analysis of three longitudinally sampled *S. aureus* ST30 isolates collected from a single patient with cystic fibrosis over a 26-month period documented the accumulation of 23 SNPs and 15 insertions/deletions (InDels), mainly in genes involved in virulence, global regulation, metabolism, and antibiotic resistance ([@evs094-B34]).

Although progress has been made, our understanding of the evolution and dissemination of CA-MRSA as an endemic pathogen within communities is limited. Epidemiological data suggest that some of the unique characteristics of CA-MRSA include the ability to persist, cause recurrent infections, and transmit (or spread) among household members ([@evs094-B50]; [@evs094-B8]). The ability to adapt during persistent colonization may be a potential determinant of increased fitness and transmissibility of bacterial pathogens ([@evs094-B54]). Here, we performed comparative whole-genome sequence analysis of eight USA300 isolates collected from three households over a 15-month period to investigate evolution of the epidemic USA300 genome in vivo.

Materials and Methods
=====================

Ethics
------

We obtained written informed consent from each individual before conducting an interview or obtaining samples. Parental consent was required for the participation of children younger than 18 years, and pediatric assent was obtained from those capable of providing it. Index participants were compensated \$10 for their time. The Institutional Review Board of Columbia University Medical Center, New York, approved this study.

Sample Selection and Molecular Genotyping
-----------------------------------------

Between 2004 and 2007, a population-based longitudinal study, funded by the Centers for Disease Control and Prevention, was performed to determine the spread of CA-MRSA in households with an MRSA index case in Northern Manhattan. This is home to the largest Dominican community in the country (approximately 222,000). Potential study subjects were identified by a positive clinical culture with either a CA-MRSA or a hospital-associated (HA)-MRSA isolate. Patients were not eligible to participate if they were living in a nursing home or shelter or if they already had a prior positive culture for MRSA. A total of 114 eligible index cases were enrolled. The index cases and their household members were interviewed and samples (nares or open wounds) collected upon recruitment and at 4-month intervals for up to 16 months. The clinical isolate was also available for further genotyping in 67% (76) of cases. A total of 403 positive *S. aureus* samples were identified over the study period. USA300 was the predominant strain and identified at least once in 38/114 (33.3%) households. Of these, USA300 colonized or infected more than two members in seven (18.4%) households and was detectable on two or more occasions in 11/38 households. Three of these households were remarkable in that they had persistent colonization of different family members with USA300 for more than 1 year.

Molecular strain typing was carried out using PFGE, multilocus sequence typing (MLST), and *S. aureus* protein A (*spa*) sequencing (*spa*-typing) as described ([@evs094-B14]; [@evs094-B19]). In brief, *Sma*I-digested samples were subjected to PFGE ([@evs094-B7]; [@evs094-B5]). The resulting band patterns were analyzed by Bionumerics software (version 4.0, Applied Maths, Ghent, Belgium) to determine relatedness between strains ([@evs094-B45]). Profiles with \>80% similarity were considered closely related. MLST was carried out as described ([@evs094-B14]), and ST were assigned using [saureus.mlst.net](saureus.mlst.net), accessed November 30, 2012. *Spa*-typing was carried out using polymerase chain reaction sequencing, and *spa*-types were automatically assigned using Ridom Staph-Type software (version 1.5) and compared with <http://spaserver2.ridom.de>, accessed November 30, 2012.

Further screening for the presence of PVL ([@evs094-B28]), the ACME ([@evs094-B13]), and for the type of staphylococcal chromosomal cassette (SCC) *mec* was determined by PCR as described ([@evs094-B36]).

Growth Assays and Antimicrobial Susceptibility Testing
------------------------------------------------------

Bacteria were grown in trypticase soy broth (TSB, Becton Dickenson) overnight and incubated after a 1:100 dilution in microtiter plates at 37**°**C with shaking. Optical density (OD) measurements were automatically recorded every 2 min in a Victor3 microplate reader (Perkin Elmer) and used for calculation of the doubling time for each strain. Drug susceptibilities of all *S. aureus* isolates were determined by Kirby Bauer standard disk diffusion method according to the Clinical and Laboratory Standards Institute guidelines ([@evs094-B42]). The following antibiotics were tested: penicillin, cefoxitin, oxacillin, erythromycin, tetracycline, levofloxacin, gentamicin, clindamycin, trimethoprim-sulfamethoxazole, and rifampin. The mupirocin E-test was performed after inoculation of a single colony in TSB followed by incubation at 37°C. At a cell density equivalent to a 0.5 McFarland standard, bacteria were streaked evenly onto Muller Hinton agar (MHA)/5% sheep blood plates (BD). Plates were incubated at 37°C for 24 h.

Whole-Genome Comparative Sequencing and Phylogenetic Analysis
-------------------------------------------------------------

Total bacterial DNA was isolated from overnight cultures using a DNAeasy Tissue Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions, except lysostaphin was added to samples, and they were incubated for at least 3 h at 37°C. Genome sequencing was performed using a SOLiD 3 System (Applied Biosystems). Mate-pair libraries were prepared according to the manufacturer's recommendations. Raw colorspace reads generated by the SOLiD sequencer were mapped to the USA300 FPR3757 strain using Corona-Lite (Applied Biosystems) and ZOOM (Bioinformatics Solutions, Inc.). This approach gave on average 112× sequence coverage and identified all SNPs, small insertions/deletions (InDels, insertions up to 4 bp and deletions up to 11 bp), and large deletions using the USA300 FPR3757 strain as the reference strain. InDels and MGEs were verified by PCR and/or PCR-directed capillary DNA sequencing using oligonucleotide primers (Sigma Genosys, The Woodlands, TX) designed with Vector NTI software (Invitrogen Corp., Carlsbad, CA). Purified PCR products were sequenced using a 3730XL DNA analyzer at the Genomics Core Facility, Research Technologies Section, Rocky Mountain Laboratories as described previously ([@evs094-B30]). Sequences were initially aligned to strain FPR3757 ([@evs094-B12]), and SNP and non-SNP insertions, deletions and transpositions in genomic and plasmid DNA were obtained. Meta data were deposited in the NCBI short read archive (<http://www.ncbi.nlm.nih.gov/sra>, accessed November 30, 2012) under the accession number SRA059180.

Phylogenetic analyses were performed using 777 concatenated SNP nucleotides (or 806 if HOU-MR is included) in the core genome of all eight isolates compared with the FPR3757 reference strain. Alternatively, phylogenetic analyses that included strain COL and previously published USA300 isolates ([@evs094-B30]) were performed using 1,577 concatenated SNP nucleotides. Phylogenetic trees were generated by the maximum likelihood method using 1,000 bootstraps using the PhyML plugin ([@evs094-B17]) in the Geneious software package (Biomatters Ltd., New Zealand).

Analysis of Small Insertion and Deletions
-----------------------------------------

For analysis of small insertion and deletions, we determined a quality cutoff for InDels. We graphed the total coverage for every InDel called for each individual strain that showed a biasymptotic line and then identified the "break" in the line for each isolate. From this analysis, we compiled a list of the high coverage calls for InDels. For most of the isolates, this was at least a ∼10 fold coverage, but in some instances, this was lower (6-fold coverage in one case).

Results
=======

Persistence of USA300 After Infection in Households in Northern Manhattan
-------------------------------------------------------------------------

To examine the evolution of USA300 strains within community households, we selected isolates from the two households (HH1000 and HH2000) containing members that had persistent colonization with USA300 for more than 1 year ([fig. 1](#evs094-F1){ref-type="fig"}). In addition, we selected isolates from a household (HH3000) with nonpersistent colonization ([fig. 1](#evs094-F1){ref-type="fig"} and [table 1](#evs094-T1){ref-type="table"}). Notably, these isolates were selected after an initial USA300 skin infection within each household (index case) ([table 1](#evs094-T1){ref-type="table"}). F[ig]{.smallcaps}. 1.---Timeline of *Staphylococcus aureus* colonization in three community households and sample selection for whole-genome sequence comparisons. Shown are two households with persistent USA300 colonization (HH1000, left panel, and HH2000, top right panel) and one household (HH3000, lower right panel) without persistent USA300 colonization. Note that for HH1000, only the 7 colonized members of the 12 total members sharing the household are indicated. Circles indicate index infection and stars symbolize *S. aureus* colonization of household members at 2, 6, 10, or 15 months, respectively. Multiple stars indicate colonization of more than one body site. Color of stars specifies clonal type (red star, USA300 t008; orange star, USA300 spa-variant; pink, USA300 MSSA; and dark red, USA300 ACME negative). Other colors (green, blue, and yellow) symbolize non-USA300 isolates. Isolate numbers are shown for sequenced samples only. Table 1Phenotypic and Genotypic Characterization of Samples[^a^](#evs094-TF1){ref-type="table-fn"}IsolateSourceDoubling Time (min)Hemolysins*spa*PFGE rel. to USA300-0114 (%)SCC*mec*ACMEPVLOxLVXT/SEryHH1000    1001Wound58:30**α**, **δ**t00896IVa++RRSR    1002Colonizer56:55**α, δ**t00885MSSA−−SRRS    1003Colonizer58:49**α, δ**t532196IVa++RRSR    1004Colonizer59:06**α, δ**t00882IVa−+RSSR    1005Colonizer62:22**α, δ**t00896IVa++RRSRHH2000    2001Abscess61:50**α, δ**t008100IVa++RRSR    2002Colonizer66:09**α, δ**t008100IVa++RRSRHH3000    3001Abscess71:51**α++, δ**t008100IVa++RSSR[^3][^4]

The first household (HH1000) was shared by 12 members of an extended family, of which four were colonized with *S. aureus* at the time of enrollment ([fig. 1](#evs094-F1){ref-type="fig"}). Over the course of the study, 7/12 individuals were colonized with *S. aureu*s, and USA300 was the predominant pulsed-field type ([fig. 1](#evs094-F1){ref-type="fig"}). Although most USA300 isolates from this household were MRSA, *spa*-type t008, and ACME and PVL positive, there was also an methicillin susceptible *S. aureus* (MSSA) isolate (isolate 1002), a *spa*-type variant (isolate 1003), and an ACME-negative isolate (isolate 1004; [table 1](#evs094-T1){ref-type="table"}). Members of the second household (HH2000) were also colonized persistently with USA300, and all isolates were indistinguishable by conventional molecular genotyping ([table 1](#evs094-T1){ref-type="table"}). In the household containing members that were not persistently colonized by *S. aureus* (HH3000), the USA300 isolate from the index case (3001) was replaced by an unrelated MRSA strain ([fig. 1](#evs094-F1){ref-type="fig"}). Therefore, this sample selection represents a cross-sectional comparison of *S. aureus* isolates from index infections (1001, 2001, and 3001) as well as longitudinal pairs (2001 and 2002; 1001 and 1002, 1003, 1004, or 1005, respectively; [fig. 1](#evs094-F1){ref-type="fig"}).

These eight isolates differed minimally in their drug resistance profiles, hemolysis pattern, and growth characteristics, although 3001 had an increased doubling time compared with the other isolates ([table 1](#evs094-T1){ref-type="table"}).

SNPs, InDels, and Evidence of Small-Genome Rearrangements among Closely Related USA300 Isolates
-----------------------------------------------------------------------------------------------

Using comparative whole-genome sequencing, a total of 1,365 SNPs were detected in the core genome and MGEs of the eight sequenced strains compared with the genome of the USA300 reference strain (FPR3757) ([@evs094-B12]). Of these SNPs, 293 were intergenic, 429 were nonsynonymous, and 643 were synonymous. There were a combined 747 SNPs among the eight New York USA300 isolates and 777 SNPs compared with the reference genome FPR3757. Of these, 209 (26.9%) SNPs were intergenic, 319 (41.1%) were nonsynonymous, and 249 (32.0%) were synonymous. The majority of mutations (*n* = 561) were only detected in the MSSA isolate, 1002 ([fig. 2](#evs094-F2){ref-type="fig"}), 30 SNPs were found in all sequenced isolates and a combined 186 SNPs were present in the seven MRSA isolates relative to the reference strain (range was 63--113 SNPs for individual isolates) ([fig. 3](#evs094-F3){ref-type="fig"}). These SNPs clustered into 101 open-reading frames, and multiple SNPs were detected in 15 genes. F[ig]{.smallcaps}. 2.---Distribution of SNPs in the core genome of the 8 USA300 household isolates. Blue, SNP in an intergenic region; red, nonsynonymous SNP; and green, synonymous SNP. The light-purple-shaded areas indicate the position of selected MGEs in the FPR3757 reference strain. Forward (above the line) and reverse (below the line) strand open-reading frames of FPR3757 are shown in gray at the top of the aligned sequences. F[ig]{.smallcaps}. 3.---SNP matrix and SNP-based phylogenetic analysis. (*A*) SNP matrix. (*B*) Phylogenetic analysis based on 806 concatenated core genomic SNP nucleotides in the eight household USA300 isolates and strain HOU-MR relative to the FPR3757 USA300 reference strain. (*C*) Phylogenetic analysis of household isolates, geographically diverse USA300 isolates, and USA300 reference strains, based on 1,577 concatenated core genomic SNP nucleotides.

We detected similar ratios of nonsynonymous to synonymous SNPs in all but two isolates ([table 2](#evs094-T2){ref-type="table"}). The highest ratio was found in the nonpersisting isolate 3001 (3.4:1), which may indicate this isolate has undergone recent diversification ([@evs094-B6]). Table 2Summary of Mutations among MRSA IsolatesHouseStrainSNPsIGNSSRatio10001001793133142.4:11003843335152.3:11004702828142:11005823334142.4:120002001753430112.7:120021133437420.9:13000300163282783.4:1[^5]

Compared with the FPR3757 reference genome, 24 genes in the eight query isolates had regions of large deletions. These deletions were mainly located in fibronectin-binding proteins, hypothetical cytosolic proteins, or proteins of unknown function and were located in large repeat regions.

We note that ACME was absent in isolates 1004 and 1002 (MSSA), consistent with prior PCR-genotyping ([table 2](#evs094-T2){ref-type="table"}). This MSSA isolate also lacked other MGEs commonly associated with USA300, including SaPI5, ΦSA2usa, and ΦSA3usa ([fig. 2](#evs094-F2){ref-type="fig"}).

Phylogeny
---------

To determine the extent of diversity among the core genomes of the eight household isolates relative to the USA300 reference genome FPR3757, we performed phylogenetic analysis using concatenated SNP nucleotides identified in the core genome of isolates from Northern Manhattan households ([fig. 3](#evs094-F3){ref-type="fig"}*A*--*C*). This analysis indicates that MSSA isolate 1002 likely diverged earlier from a common ancestor and is not immediately related to the other USA300 isolates from HH1000 ([fig. 3](#evs094-F3){ref-type="fig"}*B*), whereas all seven USA300 MRSA isolates and HOU-MR, another reference USA300 strain ([@evs094-B24]), were more closely related. When SNPs from the core genomes of 10 previously sequenced and geographically diverse USA300 isolates were included in the phylogenetic analyses ([@evs094-B24]; [@evs094-B30]), the Northern Manhattan MRSA isolates clustered closely together and suggest a relatively recent common ancestor. Overall, these isolates were closely related to the main cluster that represents the epidemic USA300 clone ([fig. 3](#evs094-F3){ref-type="fig"}*C*).

Furthermore, isolates 2001 and 2002 (HH2000) clustered together as did most MRSA isolates from HH1000 (1001, 1005, and 1003, representing the initial clinical isolate, late colonization isolate, and *spa*-variant, respectively). However, one of the ACME-negative isolates, 1004, was less closely related to this branch and thus likely did not recently arise in HH1000. Rather, isolate 1004 was more closely related to the nonpersisting isolate (3001) from HH3000. Based on the high-resolution data obtained from whole-genome comparison and phylogenetic analysis, three distinct USA300 subclones (1001, 1002, and 1004) were likely acquired independently and introduced into HH1000. This idea contrasts with results from conventional genotyping (PFGE, *spa*-typing, and PCR typing for MGEs), which, in light of the epidemiology of the strains collected in one household, suggested immediate common ancestry of these three USA300 isolates. On the other hand, the *spa*-clustering algorithm BURP ([@evs094-B35]) predicted that isolate 1003 (*spa*-type t5321) was more distantly related to the other USA300 household isolates, but based on whole-genome sequence comparison, it is very closely related to 1001 and only differs from this isolate by two additional SNPs other than those in *spa.*

Cross-Sectional Comparison of the Three Infectious Isolates
-----------------------------------------------------------

Although index isolates 1001 and 2001 from the "persisting" households 1000 and 2000 each contained 10 or 11 unique nonsynonymous SNPs, respectively ([table 3](#evs094-T3){ref-type="table"}), they also shared seven unique nonsynonymous mutations that were not present in the "non-persisting" household (HH3000). These mutations resided within genes encoding proteins involved in replication and recombination repair, coenzyme transport, carbohydrate transport and metabolism, and genes encoding proteins of unknown function ([table 3](#evs094-T3){ref-type="table"}). Table 3Summary of Nonsynonymous SNPs and Small IndelsHousehold/isolateGeneCOGMutationHH1000/1005*ileS*JI473NZinc proteaseRP52SNicotinate phosphoribosyl transferaseHG340A*sdrC*NoneΔ75 bp SD regionHH1000/1003*spa*JME393A, Δ24 bp*gid*JA133V*Nramp*PY304FHH2000/2002CDP-ribitol-phosphotransferaseMS400N*lacC*GW218[^a^](#evs094-TF2){ref-type="table-fn"}*moeA*HM25I*hlgA*NoneD130E*hlgC*NoneL2I, L79F, L126FConserved hypothetical proteinNone9 bp insertionHH1000 and HH2000 combined, "Persisting strains"*gyrA*LL84StRNA-ArgSE17DHypothetical membrane-span proteinSD71N*parC*LY80SO2-independ.coprophyrinogen-oxidaseHT145ATransaldolaseGI6VTransporter, MMPL familyRK795QHH3000/3001, "Non-persister"Cytosolic proteinCG26D*yqiG*CA219ECell division protein *ftsH*OD336GHypothetical membrane-span proteinSP220LTranscriptional regulator, MarRKW48[^a^](#evs094-TF2){ref-type="table-fn"}Hypothetical membrane-span proteinTKW199RArogenate dehydrogenaseEG336V, Y335[^a^](#evs094-TF2){ref-type="table-fn"}Erythrocyte membrane-span proteinLVDSRMT8428S*proC*ED152N*kipl*EE60G*rpmA*JY54H*icaA*Δ5 bp (239[^a^](#evs094-TF2){ref-type="table-fn"})*lukE*NoneΔ1 bp (6[^a^](#evs094-TF2){ref-type="table-fn"})Hypothetical cytosolic proteinJN721K[^6]

The nonpersisting isolate 3001 contained 12 unique nonsynonymous SNPs in genes involved in transcription, translation, post-translational modification (cell division protein *ftsh*), energy production and conversion, protein turnover, amino acid transport, and metabolism ([table 3](#evs094-T3){ref-type="table"}). In addition, this isolate had premature stop codons in *marR* (transcriptional regulator) and *lukE* (encoding a leukocidin subunit), and a frame shift mutation in *icaA* ([table 3](#evs094-T3){ref-type="table"}).

Longitudinal Evolution of Mutations in HH1000
---------------------------------------------

Only three nonsynonymous SNPs and one deletion were identified in each, the *spa*-variant (1003), and the late colonizing isolate (1005) compared with the index isolate (1001) ([table 3](#evs094-T3){ref-type="table"}). For 1003, SNPs and a repeat deletion were detected in *spa*, consistent with the known evolution of that *spa*-type. Two additional SNPs were found in genes encoding proteins involved in translation (glucose-inhibited division protein, *gid*) or inorganic ion transport and metabolism (a homolog of natural resistance associated macrophage protein, *Nramp*) ([table 3](#evs094-T3){ref-type="table"}).

Relative to 1001, isolate 1005, a late colonizing isolate, harbored mutations in genes encoding proteins involved in translation (IleS), coenzyme transport and metabolism, and a zinc protease and a 75-bp repeat deletion in an adhesion molecule known as SdrC ([table 3](#evs094-T3){ref-type="table"}). Sequencing of additional USA300 isolates collected in household HH1000 ([table 4](#evs094-T4){ref-type="table"}) indicates co-occurrence and a possible genetic linkage of the *ileS* mutation and a 75-bp deletion within the region encoding for serine-aspartate repeats in *sdrC*. IleS is a class I tRHA synthetase and the molecular target of mupirocin. Low-level resistance (MIC = 8--256 µg/ml) has been linked to a number of mutations in *ileS* that result in changes in amino acids, such as V588F and V631F ([@evs094-B22]; [@evs094-B18]; [@evs094-B2]), affecting the interaction of mupirocin with the Rossman fold ([@evs094-B18]). Our observed I473N mutation is predicted to fall within the IleS core domain, which is contained within the Rossman fold. However, isolate 1005 is not resistant to mupirocin and the MIC (0.4 µg/ml) was identical to that of the index clinical isolate (1001) by E-test. This finding is consistent with the reported lack of exposure of family members to mupirocin during the study period. Table 4Summary of Samples and Mutations in Household 1000Sample IDTimepoint (months)PersonSourceSdrC, SAUSA300_0546IleS, SAUSA300_1087Zn prot, SAUSA300_1172Nicotinate PT, SAUSA300_1894100104ClinicalWtI473P52G340A101024ButtocksWtI473P52G340101125NasalWtI473P52G340101225AxillaWtI473P52G340101327NasalWtI473P52G340101461NasalWtI473P52G340A101565NasalΔ834-875I473NP52G3401016105NasalΔ834-875I473NP52SG3401017155NasalΔ834-875I473NP52SG3401005155AxillaΔ834-875I473NP52SG340

USA300 Mutations Unique to HH2000 and Evolution
-----------------------------------------------

In household HH2000, the index (2001) and colonizing (2002) isolates harbored mutations in five genes involved in cell wall and membrane biogenesis, carbohydrate and coenzyme transport and metabolism, and *S. aureus* virulence ([table 3](#evs094-T3){ref-type="table"}). These mutations included a missense mutation W218\* in the tagatose-6-phosphatate kinase, which is encoded by the *lacC* gene. *Staphylococcus aureus* is one of the few organisms that uses the [d]{.smallcaps}-tagatose-6-phosphate pathway exclusively to metabolize lactose and [d]{.smallcaps}-galactose. This pathway is essential for *S. aureus* survival in lactose-rich media such as milk. In its functional absence, [d]{.smallcaps}-galactose accumulates, and bacterial growth is inhibited ([@evs094-B4]).

We noted an overlap between regions of large deletions and accumulation of synonymous SNPs in two clusters of genes (*hlgA* and *hlgC*, encoding gamma-hemolysin subunits, and *tarL*, encoding CDP-ribitol ribitolphosphotransferase) in isolate 2002 from household 2000. Resequencing of these genes revealed additional nonsynonymous and synonymous SNPs, which all clustered within the 5'-region of each gene. Blast searches of these selected regions revealed a chimeric gene, in which the first 372 bp were consistent with the *hlgA* sequence, and the remainder of the gene (573 bp) was replaced by *hlgC* sequence ([fig. 4](#evs094-F4){ref-type="fig"}). This orientation was further verified by locus-spanning PCR. However, no additional sequence changes were observed in the adjacent *hlgC* or *hlgB* genes. The putative breakpoint followed a region of 17-bp homology containing two long A stretches positioned at the 3'-end of a 200-bp region of ∼80% nucleotide identity. F[ig]{.smallcaps}. 4.---Small region genome rearrangement. Schematic representation of small genome rearrangement within the *hlgACB* locus.

Isolate 2002 harbored an additional putative gene rearrangement in a tandem gene cluster. Similar to *hlgA*, the *tarL* gene (encoding CDP-ribitol ribophosphatase, SAUSA300_0251) had 456 bp at the 3'-end of the gene replaced by sequence from the upstream-located paralog *tarB* (SAUSA300_0247) in isolate 2002. No additional changes were noted within this locus that also contains other enzymes of the teichoic cell wall synthesis machinery ([@evs094-B40]).

All the SNPs and areas of genome rearrangements were also present in all additional USA300 isolates from this household from timepoint 3 onward ([fig. 1](#evs094-F1){ref-type="fig"}) but not at the beginning of the study period, suggesting that isolate 2002 had replaced 2001 among household members (not shown).

Discussion
==========

Using genome-wide analysis of sequentially sampled USA300 isolates from three community households, we discovered that there was limited evolution of these subclones over a ∼15-month period. Despite this finding, there were noted changes in the DNA of these isolates, and they mainly occurred in genes that encoded for major aspects of *S. aureus* function, such as cell adhesion, cell wall biosynthesis, virulence, and carbohydrate metabolism. On the basis of the close epidemiological relationship of the sequenced household isolates, we were also able to identify regions of small genome rearrangements within two multigene operons. Although large genome replacements have been recognized as a means of major clone evolution, such as for ST239 ([@evs094-B41]), small genome rearrangements within operons may represent a more common and previously underappreciated mechanism of *S. aureus* evolution and adaptation.

Most of the biological and genome differences were observed between the persisting and nonpersisting USA300 isolates. Although almost all isolates harbored a relatively high number of nonsynonymous mutations relative to synonymous mutations, the strain with the highest nonsynonymous-to-synonymous SNP ratio did not persist. This preferential accumulation of nonsynonymous SNPs may indicate the recent emergence of slightly deleterious mutations, and thus, purifying selection has not yet occurred ([@evs094-B6]). In addition, this isolate was noted to have a decreased doubling time and harbor a premature stop codon in the transcriptional regulator *marR,* consistent*.*

Although this study did not allow for a calculation of the USA300 mutation rate, it suggests a limited accumulation of novel SNPs (only three SNPs in each, HH1000 and HH2000) over the 15-month study period appears. These numbers appear in contrast to the hospital-associated *S. aureus* isolates of the ST239 lineage, in which the estimated rate of mutation is one SNP every 6 weeks ([@evs094-B20]). This may indicate that the household isolates studied here already had reached an equilibrium in host adaptation to genetically closely related individuals. As a parallel, host imprinting and divergent adaptation of bacteria to individual patients has been suggested in asymptomatic *Escherichia coli* bacteriuria patients ([@evs094-B54]). Here, the repeated exposure of patients to the identical *E. coli* isolate led to the repeated individual-specific evolution of almost all genomic changes. Alternatively, the difference in SNP frequency between the household and hospital-associated isolates emphasizes the potential role of high-level antibiotic pressure in driving evolution of *S. aureus* strains. It should be noted, however, that approximately 50% of healthy individuals residing in this study community report some antibiotic use over a 6-month period ([@evs094-B48]).

Although the majority of longitudinally evolved SNPs were isolate specific, the long-term persisting isolates from both households underwent adaptation in molecules implicated in bacterial adhesion to human host cells, namely a truncation of SD repeats in *sdrC* in isolate 1005 and a small gene rearrangement in the *tarL* gene in isolate 2002. SdrC belongs to the multigene family of surface receptors that promote attachment to host extracellular matrix proteins ([@evs094-B27]). SdrC is believed to play a role in the multifactorial process of binding to desquamated nasal epithelial cells ([@evs094-B52]; [@evs094-B9]) and to the neuronal cell adhesion molecule β-neurexin ([@evs094-B3]). Although much of the biology of SdrC remains unknown, it shares most of its structural organization with clumping factor A (ClfA), a closely related member of the MSCRAMM family ([@evs094-B27]). A previous study provided evidence that the number of SD repeats in ClfA plays an important role in modulating the proper display of domain A, thereby allowing subsequent binding of ClfA to fibrinogen ([@evs094-B21]). This finding suggests an important regulatory role for variable SD repeat units in other members of this gene family such as SdrC. Deletions or insertions of SD repeats in SdrC may provide a rapid mechanism of optimized binding to host cells and colonization of a particular human host. The ability to adhere to human cells may have further been altered by the gene rearrangement in *tarL*. This gene is thought to encode for the CDP-ribitol ribitolphospho-transferase (EC 2.7.8.14), which is involved in wall teichoic acid (WTA) synthesis ([@evs094-B40]). A *S. aureus* mutant devoid of WTA showed a complete lack of nasal colonization and endovascular infections and was more resistant to human β-defensin 3 ([@evs094-B51], [@evs094-B52]; [@evs094-B31]). The observed reassembly of one of the enzymes in the WTA machinery may allow for adaptive colonization and persistence in a particular human host. We also observed an apparently genetically linked second small genome rearrangement in the gamma-hemolysin operon in the same isolate. Gamma-hemolysin is a bicomponent pore-forming leukotoxin encoded by three genes, *hlgA*, *hlgB*, and *hlgC*, all within the same operon. *hlgA* and *hlgC* encode LukS subunits, and *hlgB* encodes a LukF subunit. These subunits assemble as either HlgAB or HlgCB, and both forms have potent hemolytic and leukotoxic activity with differing cell tropism ([@evs094-B43]). Gamma-hemolysin subunits are highly upregulated by USA300 in blood, although the toxin may only have a modest contribution to virulence ([@evs094-B32]). Variation of the composition of the LukS subunit may potentially allow a subtle adaptation of *S. aureus* for host cell tropism or manifest loss of virulence factors as has been suggested for bacteria during their chronic colonization state ([@evs094-B54]; [@evs094-B34]). In addition, leukotoxins are now known to enhance or directly trigger the host inflammatory response ([@evs094-B55]; [@evs094-B16]; [@evs094-B33]; [@evs094-B53]), which would suggest an important role of the rearrangements in antigenic diversification and environmental host adaptation.

Rapid diversification of surface proteins encoded by paralogous tandem gene clusters genes have been recognized in many different bacterial species ([@evs094-B49]) via multiple different molecular mechanisms such as inversion, deletion, gene conversion via recombination, or slipped strand mispairing during DNA replication. Our findings here are consistent with sequential homologous recombination, gene duplication, and generation of chimeric gene sequences in the *tarLB* and *hlgAC* loci. However, the small sample size precludes the exact mapping of the putative breakpoints. Additional evidence for gene rearrangements in *S. aureus* has also been detected in the *ssl* and *lpl* clusters, likely due to multiple rounds of unequal crossing-over events between sister chromosomes around centrally conserved sequences ([@evs094-B46]; [@evs094-B47]).

Limitations of this study include the relatively small number of sequenced isolates. However, using this high-resolution sequence analysis, we were also able to reclassify three possible transmission events within one household when compared with a combination of conventional typing techniques, including *spa*, MLST, and PFGE. The direct implication of this refined typing technique is that USA300 was introduced at least three times into a single community household (HH1000). This suggests that members of this household either had continuous exposure to one or several unidentified high-risk reservoirs in their social networks or potentially harbored a genetic predisposition for colonization with ST8 *S. aureus*. As whole-genome sequencing becomes more affordable and sequence analysis more efficient, these tools will greatly aid in refining epidemiological investigations.

The phylogenetic analysis incorporating geographically diverse USA300 isolates ([@evs094-B30]) suggested that all USA300 MRSA household isolates have evolved as a single clade in the Northern Manhattan community from a relatively recent common ancestor within the epidemic USA300 cluster. This further illustrates the importance of local communities as reservoirs for transmission and spread of endemic *S. aureus* clones such as USA300.
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[^2]: **Data deposition:** NCBI short read archive: <http://www.ncbi.nlm.nih.gov/sra>. Accession SRA059180.

[^3]: N[ote]{.smallcaps}.---Ox, oxacillin; LVX, levofloxacin; T/S, trimethoprim/sulfamethoxazole; Ery, erythromycin.

[^4]: ^a^All isolates were resistant to penicillin but sensitive to vancomycin, linezolid, tetracycline, and rifampin. All isolates were ST8 by MLST.

[^5]: N[ote]{.smallcaps}.---IG, intergenic; NS, nonsynonymous SNP; S, synonymous SNP.

[^6]: ^a^Missense mutation.
